SciClone Pharmaceuticals Inc (NASDAQ:SCLN)

7.71
Delayed Data
As of Feb 27
 0.00 / 0.00%
Today’s Change
4.24
Today|||52-Week Range
9.14
-11.99%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Revenue and IncomeNet Revenues85.1M133.6M156.3M127.1M
 
 
 
 
 
Cost of Goods Sold12.1M19.5M22.0M17.7M
 
 
 
 
 
Depreciation And Amortization556.0K2.9M3.4M860.0K
 
 
 
 
 
 
Operating ExpensesGross Income72.4M111.2M130.8M108.5M
 
 
 
 
 
General Expenses50.0M81.4M92.2M94.9M
 
 
 
 
 
Other Operating Expenses0.000.003.8M0.00
 
 
Research And Development12.4M12.3M4.3M6.6M
 
 
 
 
 
Total Operating Expenses62.7M103.9M121.5M113.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income22.4M29.7M34.8M13.6M
 
 
 
 
 
Extraordinary Credit0.003.5M15.4M600.0K
 
 
 
 
Extraordinary Charge0.00-3.8M-43.8M-1.2M
 
 
 
 
Interest Expense On Debt195.0K213.0K185.0K103.0K
 
 
 
 
 
Other Expenses953.0K-21.0K-42.0K195.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income23.3M29.3M6.3M13.2M
 
 
 
 
 
Income Taxes-2.2M-798.0K-3.3M-2.2M
 
 
 
 
 
Net Income21.1M28.5M9.6M11.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS47.6M55.1M56.6M53.6M
 
 
 
 
 
Shares To Calculate EPS Diluted49.4M57.4M58.5M54.9M
 
 
 
 
 
 
Earnings Per ShareEPS$0.43$0.50$0.16$0.20
 
 
 
 
 
EPS Diluted$0.43$0.50$0.16$0.20
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account